Final Flashcards

1
Q

OXT

A

synthesized by magnocellular neurons, released through post. pituitary into general circulation
mech. stim (↑ pressure of cervix/myometrial contractions/suckling stim) triggers secretion from pituitary → stimulates OXT Rs in uterus/smooth m. of milk ducts in mammary glands = ↑ contraction
positive feedback: mechanoreceptors send impulses to hypot = ↑ OXT
also bonding effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

vasopressin

A

synthesized by magnocellular neurons, released through post. pituitary into general circulation
↑ blood osmolarity/↓bp/↓blood vol triggers secretion from pituitary
kidneys: insertion of aq-2 channels = ↑ water reabsorption
vasculature: vasoconstriction
anterior pituitary: ACTH release

inhibited by alcohol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

GH

A

pulsatile release from somatotrophs in anterior pituitary
bone: induces growth (postnatal)
muscle: ↑ aa uptake
adipocytes: ↑ lipolysis + ↓ body fat
liver: secretion of IGF-1

therapeutic use: replacement therapy - inj
tx of pituitary dwarfism + adult GH deficiency, short stature of Turner’s syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

GH regulators

A

GHRH: positive central regulator = ↑ gene expr, ↑ GH release, induces somatotroph growth
STT: neg central regulator = ↓ GH release
ghrelin: pos peripheral reg = ↑ GH release from somatotrophs, ↑ GHRH + ↓ STT
IGF-1: neg peripheral reg = ↓ GHRH + ↑ STT, ↓ GH release
GH: autocrine factor - neg feedback

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

pegvisomant

A

recombinant GH antagonist
tx of acromegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

octreotide

A

STT receptor agonist
tx of acromegaly + gigantism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

cortisol

A

circadian rhythm/stress induce hypot. release of CRH → corticotrophs = release of ACTH → synthesis of cholesterol in adrenal cortex = ↑ cortisol
negative feedback = inhibit CRH + ACTH → terminate stress response
bound to CBG (+ albumin) = inactive
inactivated by 11βHSD2 in kidney to cortisone; reactivated by 11βHSD1 in liver

release from CBG - cross cell membrane - binds GR → translocation to nucleus → dimerizes = genomic effects (transactivation or transrepression)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

17α hydroxylase

A

metabolism of pregnenolone in z. fasciculata + reticularis = involved in cortisol + androgen synthesis
inhibited by ketoconazole in tx of Cushings and prostate cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

21β hydroxylase

A

metabolism of pregnenolone in z. fasciculata + glomerulus = involved in cortisol + aldosterone synthesis
genetic mutation or immune response = primary adrenal insufficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

11β hydroxylase

A

metabolism of pregnenolone in z. fasciculata + glomerulus = involved in cortisol + aldosterone synthesis
inhibited by metyrapone = tx of cushings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

hydrocortisone

A

glucocorticoid replacement therapy
fails to replicate circadian rhythym of cortisol secretion
Chronocort = better mimic → tx for congenital adrenal hyperplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

prednisone

A

4x ↑ potency = greater affinity for GR receptor than cortisol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

dexamethasone

A

30x ↑ potency = greater affinity for GR receptor (no MR interaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

vamolorone

A

selective glucocorticoid receptor modulator
favours transrepressing actions (anti-infl) of GR over transactivating (side effects)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ketoconazole

A

antifungal, inhibitor of 17α hydroxylase
tx of Cushing’s disease - ↓ synthesis of cortisol + androgens
side effects: ↑ P and aldosterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

metyrapone

A

inhibitor of 11β hydroxylase = ↓ cortisol + aldosterone
tx of Cushing’s disease
side effects: chronic use may cause hirsutism + hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

mifepristone

A

GC antagonist (high affinity for GR)
tx of inoperable patients with ectopic ACTH secretion or adrenal carcinoma

SPRM: selective P antagonist → ↓ embryo implantation
emergency contraception - single dose in late follicular phase inhibits LH surge = no ovulation
combined with misoprostol = medical 1st trimester abortion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

estrogen

A

converted from androstenedione by aromatases
promote females sex development, growth, + endometrial proliferation
↑ binding proteins, ↑ HDL, ↓ LDL, kidney: salt + water retention
therapeutic uses: replacement therapy, contraception, menopause
adverse effects: ↑ cancer risk (breast, endometrial), thrombosis, edema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

anastrozole

A

antiestrogen = inhibitor of aromatase → ↓ E synthesis
tx of early + advanced ER+ reast cancer in postmenopausal women
no ↑ risk for uterine cancer or thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

clomiphene citrate

A

SERM → blocks ERs in hypot. + pit. - no negative feedback = ↑ gonadotropins
tx: induce ovulation, infertility, amenorrhea, PCOS
adverse effects: ovarian cysts, hot flashes, multiple births

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

tamoxifen

A

SERM, prodrug (CYP2D6 → endoxifen)
combined with SSRIs (↓ CYP2D6) to ↓ hot flashes
tx of breast cancer; osteoporotic
adverse effects: ↑ risk of uterine cancer, blood clots

22
Q

raloxifen

A

SERM = neutral in uterine tissue = no ↑ risk of cancer
still risk of blood clots

23
Q

fulvestrant

A

SERD → binds ER monomer + prevents dimerization = degradation through ubiquitin pathway
tx of metastatic ER+ breast cancer
inhibits growth of tamoxifen-resistant tumors

24
Q

PROTACs

A

proteolysis targeting chimeras = bind ER + E3 ligase = induce ubiquitination → degradation of ER
tx of ER+ breast cancer

25
progesterone
bound to albumin facilitates implantation + pregnancy maintenance; development of mammary gland; immune role; neuroprotective abnormal P responses: endometrial cancer, endometriosis, breast cancer, uterine fibroids, PMS/PMDD, lactation therapeutic uses: hormonal contraception, menopause, dysmenorrhea, endometriosis
26
ulipristal acetate
SPRM tx of uterine fibroids; emergency contraceptive - prevent/delay ovulation) caused liver damage
27
levonorgestrel
Plan B - progestin = emergency contraceptive prevents/delays ovulation + impairs luteal function
28
testosterone
secreted by Leydig cells when stimulated by LH bound to SHBG therapeutic uses: replacement therapy (hypogonadism: 1 = ↓T, ↑FSH/LH; 2 = ↓FSH/LH → ↓ T; pituitary deficiency, aging); protein anabolic agents; osteoporosis antiandrogens: tx of benign prostatic hyperplasia, prostate cancer
29
abiraterone acetate
2nd gen antiandrogen → inhibits 17α hydroxylase and 17, 20 lyase tx of androgen dependent prostate cancer adverse effects: cortisol deficiency
30
finasteride
5α reductase inhibitor = prevents T conversion to DHT tx of BPH; ↓ risk of impotence, infertility, ↓ libido
31
flutamide
competitive antagonist of AR tx of prostate cancer → mutation of AR can cause resistance
32
darolutamide
2nd gen AR blocker inhibits both WT and mut AR; more potent
33
SARMs
tx for osteoporosis (selective for bone) → attracted sports doping risks: ↑ heart attack/stroke, hallucinations, infertility
34
AAS
mimic T ↑ muscle mass + strength many adverse effects
35
cocaine
ester local anesthetic metabolism by plasma cholinesterase to PABA short half life
36
lidocaine
amide local anesthetic high protein binding metabolized in liver, slower = can accumulate max safe dose = 5mg/kg
37
bupivocaine
cardiotoxic → R(+) binds cardiac Na+ channels max safe dose = 2mg/kg
38
sevoflurane
inhalational anesthetic
39
propofol
IV anesthetic rapid onset (lipid soluble) + emergence (rapid clearance) anti emetic + anticonvulsant positive allosteric modulator of GABA A receptor → ↑ Cl- mvt = inhibition
40
ketamine
IV anesthetic NMDA R antagonist analgesia + (dissociative) anesthetic CV stability: ↑ hr + bp
41
montelukast
LTB4 antagonist
42
misoprostol
synthetic PGE1 uses: labor induction, tx of gastric ulcers
43
glucocorticoids
induce lipocortin = inhibit PLA2 (indirect inhibition of COX)
44
NSAIDs
analgesic, anti pyretic, anti inflammatory inhibit COX = ↓ PG synthesis inhibit PGE2 in hypothalamus = antipyretic action adverse effects: gastric ulcers
45
ASA
anti infl: ↓ adhesion + migration of immune cells; prevent infl cascade anti pyretic: ↓ PGE2 in hypot antiplatelet: irreversible antagonist of TXA2 in platelets (low dose = ↓ CV risk) risks: gastric irritation, Reye's Syndrome, renal effects
46
ibuprofen
more potent than ASA = analgesia at lower dose (↓ risk of gastric ulcers) ↑ risk of hypertension
47
indomethacin
inhibits both COX + PLA2 tx of gout
48
celecoxib
selective COX2 inhibitor no antiplatelet action, ↓ gastric irritation tx of arthritis risk: ↑ MI/stroke
49
acetaminophen
analgesic + anti pyretic (less effect on COX) tx of mild pain, fever in children (↓ risk of Reye's) liver toxicity → buildup of toxic metabolite
50
N-acetylcysteine
tx of acetaminophen-induced liver toxicity
51
hormonal contraceptives
progestin: ↓GnRH = ↓LH = no ovulation; ↓ sperm survival estrogen: ↓ GnRH = ↓ LH = no ovulation; prevent development of dominant follicle
52
prostate cancer
preventative/early stage → tx = HRT (↑T) advanced → tx = antiandrogens